Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Immunotherapy|February 19, 2020
Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patientsPieter van Paassen, David Pittrow, Clemens Scheidegger, et al.Cellular Microbiology|April 24, 2004
Cryptococcal glucuronoxylomannan interferes with neutrophil rolling on the endotheliumPauline M Ellerbroek, Laurien H Ulfman, Andy I Hoepelman, et al.Current Medicinal Chemistry|February 3, 2004
Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediatorsPauline M Ellerbroek, Annemiek M E Walenkamp, Andy I M Hoepelman, et al.Infection and Immunity|August 17, 2002
Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cellsPauline M Ellerbroek, Andy I M Hoepelman, Floor Wolbers, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 27, 2023
Development of a primary care screening algorithm for the early detection of patients at risk of primary antibody deficiencyMarianne A Messelink, Roos M Berbers, Joris M van Montfrans, et al.FEMS Yeast Research|May 16, 2006
The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endotheliumFrank E J Coenjaerts, Andy I M Hoepelman, Jelle Scharringa, et al.Emerging Infectious Diseases|January 27, 2016
Hospital Preparations for Viral Hemorrhagic Fever Patients and Experience Gained from Admission of an Ebola PatientJ J Mark Haverkort, A L C Ben Minderhoud, Jelte D D Wind, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migrationPauline M Ellerbroek, Dirk J Lefeber, Richard van Veghel, et al.Immunotherapy|June 18, 2024
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization studyPauline M Ellerbroek, Leif G Hanitsch, Torsten Witte, et al.Journal of Clinical Immunology|September 30, 2025
CVID Enteropathy Is Difficult To Treat and Shows a Heterogeneous HistopathologyNoah M Juliana, Mirjam Severs, Jan Willem Marsden, et al.Pageof 2